Latest news
Lexicon Pharmaceuticals (LXRX) Nears Key HCM Readout On An Undervalued Narrative - SahmSahm · Tue, 28 Jul 2026 07:00:00 GMTLexicon Pharmaceuticals Completes Enrollment of Pivotal Phase 3 SONATA-HCM Study of Sotagliflozin in Symptomatic Non-Obstructive and Obstructive Hypertrophic Cardiomyopathy (HCM) - Yahoo FinanceYahoo Finance · Mon, 27 Jul 2026 07:00:00 GMTLexicon's HCM study spans 20 countries; results anticipated Q1 2027 - stocktitan.netstocktitan.net · Mon, 27 Jul 2026 07:00:00 GMT